Track record · closed signal

Novo Nordisk A/S (NVO) — closed signal from March 29, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on June 27, 2026.

Predicted vs. what happened

NVO price · publication thesis → realized outcomesplit-adjusted
$36.04 Published $41.81 Target $48.07 Window close $48.50 Peak
$35.00 – $36.75Entry zone — fair-value band
$36.04Published — price the day we called it
$41.81Target — the price the thesis aimed for
$48.50Peak — highest point inside the window, not a realized return
$48.07Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 30 days.

Peak price
$48.50
peak on June 26, 2026 — not a realized return
Peak gain
+34.6%
peak, from the publication price
Window close
$48.07
end-of-window price, context only
Days to target
30
Window
March 29, 2026 – June 27, 2026

The thesis — published March 29, 2026

Predicted growth
+16%
over the measurement window
Target price
$41.81
the price the thesis aimed for
Entry zone
$35.00 – $36.75
the fair-value band we waited for
Price at publication
$36.04
published March 29, 2026
Confidence
75%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Novo Nordisk looks like a rebound play after a sharp selloff. The FDA approval for a higher Wegovy dose could lift sentiment while the company still earns strong profits from diabetes and obesity drugs globally. The stock looks more balanced now, but rules on pricing and whether growth can pick up again are the main short-term risks.

Primary drivers

  • Approval of a higher Wegovy dose gives a near-term positive event
  • Obesity and diabetes products remain central to the company's profits
  • Lower valuation makes a recovery setup more attractive now
  • Early signs of price repair indicate selling may be easing

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All NVO signals